Literature DB >> 30597635

Reproducible detection of nigral iron deposition in 2 Parkinson's disease cohorts.

Jason Langley1, Naying He2, Daniel E Huddleston3, Shengdi Chen4, Fuhua Yan2, Bruce Crosson3,5,6, Stewart Factor3, Xiaoping Hu1,7.   

Abstract

BACKGROUND: Previous studies investigating nigral iron accumulation used T2 or T2 *-weighted contrasts to define the regions of interest (ROIs) in the substantia nigra with mixed results. Because these contrasts are not sensitive to neuromelanin, ROIs may have inadvertently missed the SNpc. An approach sensitive to neuromelanin should yield consistent results. We examine iron deposition in ROIs derived from neuromelanin-sensitive and T2 *-weighted contrasts, respectively.
METHODS: T1 -weighted and multiecho gradient echo imaging data were obtained in 2 cohorts. Multiecho gradient echo imaging data were analyzed using neuromelanin-sensitive SNpc ROIs as well as T2 *-weighted SNr ROIs.
RESULTS: When compared with controls, significantly larger R2 * values were seen in the SNpc of PD patients in both cohorts. Mean R2 * values in the SNr of PD patients showed no consistency, with 1 cohort showing a small, statistically significant increase, whereas the other cohort exhibited no statistical difference.
CONCLUSION: Mean R2 * in the SNpc defined by neuromelanin-sensitive MRI is significantly increased in PD.
© 2018 International Parkinson and Movement Disorder Society. © 2018 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  MRI; Parkinson's disease; iron; neuromelanin; substantia nigra pars compacta

Mesh:

Substances:

Year:  2018        PMID: 30597635      PMCID: PMC6608731          DOI: 10.1002/mds.27608

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  39 in total

1.  T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content.

Authors:  J Vymazal; A Righini; R A Brooks; M Canesi; C Mariani; M Leonardi; G Pezzoli
Journal:  Radiology       Date:  1999-05       Impact factor: 11.105

2.  Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence.

Authors:  J M Graham; M N Paley; R A Grünewald; N Hoggard; P D Griffiths
Journal:  Brain       Date:  2000-12       Impact factor: 13.501

Review 3.  Neuromelanin in the human brain: a review and atlas of pigmented cells in the substantia nigra.

Authors:  K G Usunoff; D E Itzev; W A Ovtscharoff; E Marani
Journal:  Arch Physiol Biochem       Date:  2002-10       Impact factor: 4.076

4.  Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease.

Authors:  Makoto Sasaki; Eri Shibata; Koujiro Tohyama; Junko Takahashi; Kotaro Otsuka; Kuniaki Tsuchiya; Satoshi Takahashi; Shigeru Ehara; Yasuo Terayama; Akio Sakai
Journal:  Neuroreport       Date:  2006-07-31       Impact factor: 1.837

5.  The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease.

Authors:  P Damier; E C Hirsch; Y Agid; A M Graybiel
Journal:  Brain       Date:  1999-08       Impact factor: 13.501

6.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

7.  Midbrain iron content in early Parkinson disease: a potential biomarker of disease status.

Authors:  W R Wayne Martin; Marguerite Wieler; Myrlene Gee
Journal:  Neurology       Date:  2008-01-02       Impact factor: 9.910

8.  Magnetic resonance relaxometry in Parkinson's disease.

Authors:  F Mondino; P Filippi; U Magliola; S Duca
Journal:  Neurol Sci       Date:  2002-09       Impact factor: 3.307

9.  MRI assessment of basal ganglia iron deposition in Parkinson's disease.

Authors:  Lauren I Wallis; Martyn N J Paley; Jacqueline M Graham; Richard A Grünewald; Emma L Wignall; Harriet M Joy; Paul D Griffiths
Journal:  J Magn Reson Imaging       Date:  2008-11       Impact factor: 4.813

10.  MRI evaluation of the basal ganglia size and iron content in patients with Parkinson's disease.

Authors:  Paraskevi Kosta; Maria I Argyropoulou; Sofia Markoula; Spyridon Konitsiotis
Journal:  J Neurol       Date:  2005-06-29       Impact factor: 6.682

View more
  15 in total

Review 1.  Parkinson's disease and iron.

Authors:  Hideki Mochizuki; Chi-Jing Choong; Kousuke Baba
Journal:  J Neural Transm (Vienna)       Date:  2020-02-05       Impact factor: 3.575

2.  Ventral posterior substantia nigra iron increases over 3 years in Parkinson's disease.

Authors:  Niels Bergsland; Robert Zivadinov; Ferdinand Schweser; Jesper Hagemeier; David Lichter; Thomas Guttuso
Journal:  Mov Disord       Date:  2019-06-10       Impact factor: 10.338

3.  Characterization of age-related microstructural changes in locus coeruleus and substantia nigra pars compacta.

Authors:  Jason Langley; Sana Hussain; Justino J Flores; Ilana J Bennett; Xiaoping Hu
Journal:  Neurobiol Aging       Date:  2019-11-29       Impact factor: 4.673

4.  Iron-sensitive magnetic resonance imaging in Parkinson's disease: a systematic review and meta-analysis.

Authors:  Se Jin Cho; Yun Jung Bae; Jong-Min Kim; Hyun Jin Kim; Sung Hyun Baik; Leonard Sunwoo; Byung Se Choi; Cheolkyu Jung; Jae Hyoung Kim
Journal:  J Neurol       Date:  2021-04-29       Impact factor: 4.849

Review 5.  Multimodal brain and retinal imaging of dopaminergic degeneration in Parkinson disease.

Authors:  Jee-Young Lee; Antonio Martin-Bastida; Ane Murueta-Goyena; Iñigo Gabilondo; Nicolás Cuenca; Paola Piccini; Beomseok Jeon
Journal:  Nat Rev Neurol       Date:  2022-02-17       Impact factor: 44.711

6.  Multimodal assessment of nigrosomal degeneration in Parkinson's disease.

Authors:  Jason Langley; Daniel E Huddleston; Bruce Crosson; David D Song; Stewart A Factor; Xiaoping Hu
Journal:  Parkinsonism Relat Disord       Date:  2020-09-16       Impact factor: 4.891

7.  Modulation effect of substantia nigra iron deposition and functional connectivity on putamen glucose metabolism in Parkinson's disease.

Authors:  Zhenxiang Zang; Tianbin Song; Jiping Li; Shaozhen Yan; Binbin Nie; Shanshan Mei; Jie Ma; Yu Yang; Baoci Shan; Yuqing Zhang; Jie Lu
Journal:  Hum Brain Mapp       Date:  2022-04-26       Impact factor: 5.399

8.  Brain Hepcidin Suppresses Major Pathologies in Experimental Parkinsonism.

Authors:  Tuo Liang; Zhong-Ming Qian; Ming-Dao Mu; Wing-Ho Yung; Ya Ke
Journal:  iScience       Date:  2020-06-19

9.  Parkinson's disease multimodal imaging: F-DOPA PET, neuromelanin-sensitive and quantitative iron-sensitive MRI.

Authors:  Pierre Maquet; Gaëtan Garraux; Frédérique Depierreux; Eric Parmentier; Laurane Mackels; Katherine Baquero; Christian Degueldre; Evelyne Balteau; Eric Salmon; Christophe Phillips; Mohamed Ali Bahri
Journal:  NPJ Parkinsons Dis       Date:  2021-07-08

10.  Iron Imaging as a Diagnostic Tool for Parkinson's Disease: A Systematic Review and Meta-Analysis.

Authors:  Nadya Pyatigorskaya; Clara B Sanz-Morère; Rahul Gaurav; Emma Biondetti; Romain Valabregue; Mathieu Santin; Lydia Yahia-Cherif; Stéphane Lehéricy
Journal:  Front Neurol       Date:  2020-05-28       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.